Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Markets around the world, including the US and China, all took a big drop during the uncertainty surrounding President ...

Good relative valuations and an encouraging price action led me to view healthcare positively while keeping in mind the ...

Explore why equity markets stay resilient despite uncertainties. Assess if current high valuations signal opportunity or risk ...

The mood is better than the numbers suggest. The doom-loop panic of March and April is behind us, even though the XBI has ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

Top Create Biotech has filed for an initial public offering. The biotechnology company said Wednesday that it intends to list shares under the ticker symbol TCBG on the Nasdaq Capital Market. Top ...

Today, a micro-cap biotech company made a significant announcement in this ... reaching a broad audience of investors and ...

Jyong Biotech Ltd. (Nasdaq:MENS), a biotechnology company centered on scientific development of botanical drug therapies, has marked its official listing on the Nasdaq Composite.

According to Benzinga Pro, Krystal Biotech's peer group average for short interest as a percentage of float is 13.11%, which ...

Recursion Pharmaceuticals RXRX is redefining the traditional model of drug discovery by harnessing the power of artificial intelligence (AI) through its proprietary RecursionOS platform, developed in ...

Complete Zhengye Biotechnology Holding Ltd. stock information by Barron's. View real-time ZYBT stock price and news, along with industry-best analysis.